loading...| Preferred Name | Phosphorylation of IRF-3/IRF7 and their release from the activated TLR complex | |
| Synonyms |
|
|
| Definitions |
has a Stoichiometric coefficient of 2 Edited: Shamovsky, V, 2011-08-12 Reviewed: Fitzgerald, Katherine A, 2012-11-13 Authored: de Bono, B, 2005-08-16 10:54:15 Reviewed: Gay, NJ, 2006-04-24 16:48:17 Human IRF-3 is activated through a two step phosphorylation in the C-terminal domain mediated by TBK1 and/or IKK-i. It requires Ser386 and/or Ser385 (site 1) and a cluster of serine/threonine residues between Ser396 and Ser405 (site 2) [Panne et al 2007]. Phosphorylated residues at site 2 alleviate autoinhibition to allow interaction with CBP (CREB-binding protein) and facilitate phosphorylation at site 1. Phosphorylation at site 1 is required for IRF-3 dimerization.<p>IRF-3 and IRF-7 transcription factors possess distinct structural characteristics; IRF-7 is phosphorylated on Ser477 and Ser479 residues [Lin R et al 2000]. TRAF6 mediated ubiquitination of IRF7 is also required and essential for IRF7 phosphorylation and activation. The K-63 linked ubiquitination occurs on the last three C-terminal lysine sites (positions 444, 446, and 452) of human IRF7 independently of its C-terminal functional phosphorylation sites.[Ning et al 2008]. Reviewed: Gillespie, ME, 2010-11-30 has a Stoichiometric coefficient of 6 |
|
| ID |
http://purl.obolibrary.org/obo/HINO_0009341 |
|
| comment |
has a Stoichiometric coefficient of 2 Edited: Shamovsky, V, 2011-08-12 Reviewed: Fitzgerald, Katherine A, 2012-11-13 Authored: de Bono, B, 2005-08-16 10:54:15 Reviewed: Gay, NJ, 2006-04-24 16:48:17 Human IRF-3 is activated through a two step phosphorylation in the C-terminal domain mediated by TBK1 and/or IKK-i. It requires Ser386 and/or Ser385 (site 1) and a cluster of serine/threonine residues between Ser396 and Ser405 (site 2) [Panne et al 2007]. Phosphorylated residues at site 2 alleviate autoinhibition to allow interaction with CBP (CREB-binding protein) and facilitate phosphorylation at site 1. Phosphorylation at site 1 is required for IRF-3 dimerization. IRF-3 and IRF-7 transcription factors possess distinct structural characteristics; IRF-7 is phosphorylated on Ser477 and Ser479 residues [Lin R et al 2000]. TRAF6 mediated ubiquitination of IRF7 is also required and essential for IRF7 phosphorylation and activation. The K-63 linked ubiquitination occurs on the last three C-terminal lysine sites (positions 444, 446, and 452) of human IRF7 independently of its C-terminal functional phosphorylation sites.[Ning et al 2008]. Reviewed: Gillespie, ME, 2010-11-30 has a Stoichiometric coefficient of 6 |
|
| definition source |
Pubmed10893229 Pubmed12692549 Reactome, http://www.reactome.org Pubmed17526488 Pubmed14703513 Pubmed18710948 |
|
| has input | ||
| has output |
http://purl.obolibrary.org/obo/CHEBI_16761 |
|
| label |
Phosphorylation of IRF-3/IRF7 and their release from the activated TLR complex |
|
| prefixIRI |
HINO:0009341 |
|
| prefLabel |
Phosphorylation of IRF-3/IRF7 and their release from the activated TLR complex |
|
| seeAlso |
Reactome Database ID Release 43166245 EC Number: 2.7.11 ReactomeREACT_6728 |
|
| subClassOf |